Phase II evaluation of doxorubicin plus amiodarone in advanced hepatocarcinoma.
Chauffert
B
B
Seitz
J F
JF
Bedenne
L
L
Renard
P
P
Conroy
T
T
Rougier
P
P
D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004317:Doxorubicin / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008875:Middle Aged
D004317:Doxorubicin; D000638:Amiodarone